Rosie Bradbury

Rosie Bradbury is a Senior Reporter at PitchBook News based in New York, where she covers venture capital, startups, and sector beats including health and biotech, climate tech, and emerging technologies. She joined PitchBook in March 2023 after previously reporting for the Bureau of Investigative Journalism, Business Insider, and Wired. She is best known at PitchBook for her VC market reporting and healthcare coverage, including lead stories on major biotech deals such as Eli Lilly's $7 billion acquisition of Kelonia Therapeutics. She studied History and Politics at the University of Cambridge.